论文部分内容阅读
齐二药、欣弗、刺五加、甲氨蝶呤、大连狂犬病疫苗……近年来,药品安全事件接连发生,从未淡出人们视线。仅2009年头两个月,就有糖脂宁胶囊、双黄连注射液等3起事件接连发生。沉重的生命代价刺痛着人们的神经,药品安全因此成为社会关注的热点话题。目前强生药品爆发大规模安全隐患,再一次为国人敲响了药品安全问题的警钟。药害事件为何屡禁屡发?百姓如何吃上“放心药”?公众用药应避免哪些误区?中国的药监管理制度存在哪些漏洞?本刊就此采访了北京理工大学经济学教授胡星斗。
Qi two drugs, Xin F, Acanthopanax, methotrexate, Dalian rabies vaccine ... In recent years, drug safety incidents occurred one after another, never fade out of sight. In the first two months of 2009 alone, there were 3 incidents including Gelizhining Capsule and Shuanghuanglian Injection. The heavy cost of life stung people’s nerves and drug safety has become a hot topic of social concern. At present, large-scale security risks have emerged for Johnson & Johnson’s drugs, once again sounding the alarm for drug safety issues for the people. Why do drug-related incidents continue to occur repeatedly? How do people eat “relief drugs”? What are the common pitfalls for public drug use? What are the loopholes in China’s drug regulatory system? This article interviewed Hu Xingdou, professor of economics at Beijing Institute of Technology. .